(Q51862260)

English

Caerulfin and cholecystokinin octapeptide (CCK-8): Sedative and anticonvulsive effects in mice unaffected by the benzodiazepine antagonist Ro 15-1788

scientific article published on March 5, 1982

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 April 2018

http://europepmc.org/abstract/MED/6281694

Caerulfin and cholecystokinin octapeptide (CCK-8): Sedative and anticonvulsive effects in mice unaffected by the benzodiazepine antagonist Ro 15-1788 (English)

reason for preferred rank

most precise value

1 reference

10.1016/0304-3940(82)90072-6

https://api.crossref.org/works/10.1016/0304-3940(82)90072-6

15 September 2023

Caerulein and cholecystokinin octapeptide (CCK-8): sedative and anticonvulsive effects in mice unaffected by the benzodiazepine antagonist Ro 15-1788 (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6281694

15 September 2023

cholecystokinin

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

G. Zetler

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6281694

15 September 2023

language of work or name

0 references

publication date

1 March 1982

1 reference

Europe PubMed Central

14 April 2018

http://europepmc.org/abstract/MED/6281694

5 March 1982

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6281694

15 September 2023

number of pages

4

1 reference

based on heuristic

inferred from page(s)

full work available at URL

https://api.elsevier.com/content/article/PII:0304394082900726?httpAccept=text/xml

1 reference

10.1016/0304-3940(82)90072-6

https://api.crossref.org/works/10.1016/0304-3940(82)90072-6

15 September 2023

https://api.elsevier.com/content/article/PII:0304394082900726?httpAccept=text/plain

1 reference

10.1016/0304-3940(82)90072-6

https://api.crossref.org/works/10.1016/0304-3940(82)90072-6

15 September 2023

Neuroscience Letters

1 reference

Europe PubMed Central

14 April 2018

http://europepmc.org/abstract/MED/6281694

28

1 reference

Europe PubMed Central

14 April 2018

http://europepmc.org/abstract/MED/6281694

3

1 reference

Europe PubMed Central

14 April 2018

http://europepmc.org/abstract/MED/6281694

287-290

1 reference

Europe PubMed Central

14 April 2018

http://europepmc.org/abstract/MED/6281694

Molecular Mechanisms in the Receptor Action of Benzodiazepines

1

1 reference

10.1016/0304-3940(82)90072-6

https://api.crossref.org/works/10.1016/0304-3940(82)90072-6

15 September 2023

Selective antagonists of benzodiazepines

3

1 reference

10.1016/0304-3940(82)90072-6

https://api.crossref.org/works/10.1016/0304-3940(82)90072-6

15 September 2023

Reversal of the antiaversive and anticonvulsant actions of diazepam, but not of progabide, by a selective antagonist of benzodiazepine receptors

6

1 reference

10.1016/0304-3940(82)90072-6

https://api.crossref.org/works/10.1016/0304-3940(82)90072-6

15 September 2023

Benzodiazepine Antagonist Ro 15?1788: Binding Characteristics and Interaction with Drug-Induced Changes in Dopamine Turnover and Cerebellar cGMP Levels

7

1 reference

10.1016/0304-3940(82)90072-6

https://api.crossref.org/works/10.1016/0304-3940(82)90072-6

15 September 2023

Analgesia and ptosis caused by caerulein and cholecystokinin octapeptide (CCK-8)

8

1 reference

10.1016/0304-3940(82)90072-6

https://api.crossref.org/works/10.1016/0304-3940(82)90072-6

15 September 2023

Anticonvulsant effects of caerulein and cholecystokinin octapeptide, compared with those of diazepam

9

1 reference

10.1016/0304-3940(82)90072-6

https://api.crossref.org/works/10.1016/0304-3940(82)90072-6

15 September 2023

Effects of cholecystokinin-like peptides on rearing activity and hexobarbital-induced sleep.

10

1 reference

10.1016/0304-3940(82)90072-6

https://api.crossref.org/works/10.1016/0304-3940(82)90072-6

15 September 2023

Central depressant effects of caerulein and cholecystokinin octapeptide (CCK-8) differ from those of diazepam and haloperidol

11

1 reference

10.1016/0304-3940(82)90072-6

https://api.crossref.org/works/10.1016/0304-3940(82)90072-6

15 September 2023

Differential cataleptogenic and antistereotypic effects of caerulein and haloperidol

12

1 reference

10.1016/0304-3940(82)90072-6

https://api.crossref.org/works/10.1016/0304-3940(82)90072-6

15 September 2023

Anticonvulsant effects of caerulein, cholecystokinin octapeptide (CCK-8) and diazepam against seizures produced in mice by harman, thiosemicarbazide and isoniazid

13

1 reference

10.1016/0304-3940(82)90072-6

https://api.crossref.org/works/10.1016/0304-3940(82)90072-6

15 September 2023

Cholecystokinin octapeptide, caerulein and caerulein analogues: Effects on thermoregulation in the mouse

14

1 reference

10.1016/0304-3940(82)90072-6

https://api.crossref.org/works/10.1016/0304-3940(82)90072-6

15 September 2023

Identifiers

10.1016/0304-3940(82)90072-6

1 reference

Europe PubMed Central

14 April 2018

http://europepmc.org/abstract/MED/6281694

1 reference

Europe PubMed Central

14 April 2018

http://europepmc.org/abstract/MED/6281694

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51862260&oldid=1975175562"